Vimseltinib, a new drug has been approved by the U.S. Food and Drug Administration (FDA) to treat adults with a rare rare condition called...
Vous n'êtes pas connecté
Heart disease, also called cardiovascular disease, can have serious consequences. It's the leading cause of death for adults in the U.S. Medical devices approved by the U.S. Food and Drug Administration, such as pacemakers and defibrillators, have extended and improved the lives of millions of people living with heart disease.
Vimseltinib, a new drug has been approved by the U.S. Food and Drug Administration (FDA) to treat adults with a rare rare condition called...
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular...
The US Food and Drug Administration (FDA) has approved semaglutide (Ozempic, Novo Nordisk) for reducing the risk for worsening kidney disease and...
STAMFORD, Conn., Feb. 11, 2025 -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare...
A new drug called sotagliflozin, recently approved by the U.S. Food and Drug Administration (FDA), may help people with type 2 diabetes and kidney...
COPENHAGEN, Denmark, February 14, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the U.S. Food and Drug Administration (FDA) has...
TUESDAY, Feb. 18, 2025 -- The U.S. Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for...
February 14, 2025 -- Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to NovoLog (insulin aspart) for...
Endomyocardial biopsy (EMB) is a valuable method for diagnosing a range of cardiac conditions, but there is a risk of complication due to its invasive...
A commonly used antibiotic called vancomycin, which is usually prescribed to treat infectious diarrhea, may also be helpful for people suffering from...